Showing results (191-200 of 451) with videos related to

Sort By:
Pageof 46
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 26, 2023
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABGRobert A Byrne, Stephen Fremes, Davide Capodanno, et al.
European Heart Journal|August 26, 2023
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABGRobert A Byrne, Stephen Fremes, Davide Capodanno, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2016
Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine RatioWilliam Herrington, Nicola Illingworth, Natalie Staplin, et al.
The New England Journal of Medicine|November 13, 2009
Revascularization versus medical therapy for renal-artery stenosis, Keith Wheatley, Natalie Ives, et al.
Stroke|February 2, 2008
Body mass index, blood pressure, and mortality from stroke: a nationally representative prospective study of 212,000 Chinese menMaigeng Zhou, Alison Offer, Gonghuan Yang, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Cardiovascular Drugs and Therapy|June 1, 2016
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed HyperlipidemiaRobert S Rosenson, Terry A Jacobson, David Preiss, et al.
International Journal of Epidemiology|July 28, 2006
Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'Bernard Keavney, John Danesh, Sarah Parish, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Lancet (London, England)|October 18, 2002
Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic reviewKoon K Teo, Salim Yusuf, Marc Pfeffer, et al.
Pageof 46